CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 271-285 of 889
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
CME/CE Broadcast ReplayOptimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
CME/CEThe Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer
Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Broadcast ReplayAdvances in the Treatment and Management of MASH: More Options, More Decisions
Differentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
CME/CE Broadcast ReplayDifferentiating Biomarker-Driven First-Line Treatment Strategies in Metastatic Gastric/GEJ Cancers
Love Story: Lipid Education for Women’s Heart Health
CME/CE Broadcast ReplayLove Story: Lipid Education for Women’s Heart Health
Incorporation of guidelines-concordant care for advanced NSCLC with second-line targeted therapies
MinuteCE®Incorporation of guidelines-concordant care for advanced NSCLC with second-line targeted therapies
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
MinuteCE®Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
CME/CE Broadcast ReplayIrritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Clinical evidence behind emerging targeted therapy strategies in patients with metastatic NSCLC
MinuteCE®Clinical evidence behind emerging targeted therapy strategies in patients with metastatic NSCLC
Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies
MinuteCE®Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies
Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
MinuteCE®Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
MinuteCE®Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC
Insights from global key opinion leaders on optimizing patient care in NSCLC
MinuteCE®Insights from global key opinion leaders on optimizing patient care in NSCLC
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
MinuteCE®Application of guidelines-recommended broad molecular profiling to patients with NSCLC
